диссертации / 121
.pdf101
90.Young T. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women / Young T., Evans L., Finn L., Palta M..// Sleep. – 1997. – Vol.20(9). – P.705-706.
91.Jean-Louis G. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. /Jean-Louis G., Zizi F., Clark L.T., Brown C.D., McFarlane S.I.// J Clin Sleep Med. – 2008. – Vol.4(3). – P.261-272.
92.Parish J.M. Relationship of metabolic syndrome and obstructive sleep apnea. / Parish J.M., Adam T., Facchiano L. // J Clin Sleep Med. – 2007. – Vol.3(5).
– P.467-472.
93.Kushida C.A. A predictive morphometric model for the obstructive sleep apnea syndrome. / Kushida C.A., Efron B., Guilleminault C. // Ann Intern Med. – 1997. –
Vol.127(8 Pt 1). – P.581-587.
94.Coughlin S.R Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. / Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., Wilding J.P. // Eur Heart J. – 2004. – Vol.25(9).
– P.735-741.
95.Peppard P.E. Longitudinal study of moderate weight change and sleepdisordered breathing / Peppard P.E., Young T., Palta M., Dempsey J., Skatrud J. // JAMA. - 2000. – Vol.284(23). – P.3015-3021.
96.Pincus T. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. / Pincus T., Brooks R.H., Callahan L.F. // Ann Intern Med. – 1994. – Vol.1. – P.26-34.
97.Wolfe F. The mortality of rheumatoid arthritis. / Wolfe F., Mitchell D.M., Sibley J.T., Fries J.F., Bloch D.A., Williams C.A., Spitz P.W., Haga M., Kleinheksel S.M., Cathey M.A. // Arthritis Rheum. – 1994. – Vol.37(4).
–P.481-494.
102
98. Mutru O. Cardiovascular mortality in patients with rheumatoid arthritis. / Mutru O., Laakso M., Isomäki H., Koota K. // Cardiology. – 1989. –Vol.76(1). –P.71-77.
99. Myllykangas-Luosujrvi R. Mortality in rheumatoid arthritis. / MyllykangasLuosujrvi R., Aho K., Isomaki H. // Semin. Arthritis Rheum. – 1995. – Vol. 25(3).
–P.193-202.
100.Gerli R. Cardiovascular involvement in rheumatoid arthritis. / Gerli R., Goodson N.J. // Lupus. – 2005. – Vol.14(9). – P.679-682.
101.Bergstrom U. G. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden. / Bergstrom U. G., Jacobsson L.T.H.,Turesson C. // Rheumatology. – 2009. – Vol.48. – P.1600-1605.
102.Young A. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischemic heart disease and pulmonary fibrosis. /Young A., Koduri G., Batley M., Kulinskaya E., Gough A., Norton S., Dixey J. // Rheumatology (Oxford). – 2007. – Vol.46(2). – P.350-357.
103.Maradit-Kremers H. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. A population-based cohort study. / Maradit-Kremers H., Crowson C.S., Nicola P.J. et.al. // Arthritis Rheum. – 2005.
– Vol.52(2). – P.402-411.
104.Li H.B. Risk factor assessment of cardiovascular diseases in patients with rheumatoid arthritis. / Li H.B., Bai L., Wu Q.J., Zhang X., Zhang F.C.// Zhonghua Yi Xue Za Zhi. – 2006. – Vol.86(25). – P.1769-1773.
105.Arden N.K. The increased risk of myocardial infarction in patients with rheumatoid arthritis is greatest in young women and is not due to traditional risk
103
factors. / Arden N.K., C.J. Edwards, D.J. Fisher, T. Van Staa, C. Cooper. //
Rheumatology. – 2006. – Vol.45. -Suppl 1:i1.
106.Nicola P.J. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. / Nicola P.J., Maradit-Kremers H., Roger V.L. et.al. // Arthritis Rheum. – 2005. – Vol.52(2). – P.412-420.
107.Crowson C.S. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? / Crowson C.S., Nicola P.J., Kremers H.M., O'Fallon W.M., Therneau T.M., Jacobsen S.J., Roger V.L., Ballman K.V., Gabriel S.E.// Arthritis Rheum. – 2005. – Vol.52(10). – P.3039-3044.
108.Wolfe F. Increase in cardiovascular disease prevalence in rheumatoid arthritis.
/Wolfe F., Freundlich B., Straus W.L. // J Rheumatol. – 2003. – Vol.30(1).
–P.36-40.
109.Hersi A.S. Obstructive sleep apnea and cardiac arrhythmias. / Hersi A.S.// Ann Thorac Med. - 2010. – Vol.5(1). – P.10-17.
110.Peters M.J. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other form of inflammatory arthritis. / Peters M.J., Symmons P.M., McCarey D. et.al. // Ann Rheum Dis.
–2010. – Vol.69(2). – P.325-321.
111.John H. Cardiovascular co-morbidity in early rheumatoid arthritis. /John H.,
Kitas G., Toms T., Goodson N. // Best Pract Res Clin Rheumatol. – 2009.
– Vol.23(1). – P.71-82.
112.Davis J.M. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. /Davis J.M., Roger V.L., Crowson C.S., Kremers H.M., Therneau T.M., Gabriel S.E. // Arthritis Rheum. – 2008. – Vol.289(2). – P.194-202.
104
113.Goodson N.J. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. /Goodson N.J., Marks J., Lunt M., Symmons D.// Ann Rheum Dis. – 2005. – Vol.64(11).
–P.1595-1601.
114.Schäfer H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. /Schäfer H., Koehler U., Ploch T., Peter J.H.//Chest. – 1997. – Vol.111(2). – P.387-393.
115.Young T. The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? /Young T., Hutton R., Finn L., Badr S., Palta M.//Arch Intern Med. – 1996. – Vol.156(21). – P.2445-2451.
116.Conroy R.M. Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project. /Conroy R.M., Pyorala K., Fitzgerald A.P. et.al. //Eur Heart J. – 2003. – Vol.24(11). – P.987-1003.
117.European guidelines on cardiovascular disease prevention in clinical practice:full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. – 2007. – Vol.14(2). – P.1-13.
118.Crowson C.S.Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. /Crowson C.S., Gabriel S.E.// Ann Rheum Dis. – 2011. – Vol.70(5). – P.719-721.
119.Crowson C.S. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. /Crowson C.S., Matteson E.L., Roger V.L., Therneau T.M., Gabriel S.E. // Am J Cardiol. – 2012. – Vol.110(3).
–P.420-424.
105
120.Мясоедова Е.Е. Кардиоваскулярный риск у больных ревматоидным артритом. /Мясоедова Е.Е., Шостак Н.А.// Вести Ивановской медицинской академии. – 2011. –Т.16. – №4. – C.52-57.
121.Solomon D.H. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. /Solomon D.H.// Circulation. – 2003. – Vol.107(9).
– P.1303-1307.
122.Silman A.J. Cigarette smoking increases the risk of rheumatoid arthritis. Result from a nationwide study of disease-disordant twins./ Silman A.J., Newman J., MacGregor A.J. // Arthritis Rheum. – 1996. – Vol. 39(5). – P.723-725.
123.Escalante A. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. /Escalante A., Hass R.W., del Rincon I.// Arch Intern Maed. – 2005. – Vol.165(14). – P.1624-1629.
124.Park Y.B. Lipid profiles in untreated patients with rheumatoid arthritis. /Park Y.B., Lee S.K., Lee W.K// J Rheumatol. – 1999. – Vol.26 (38). – P.1701-1704.
125.Innala L. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. /Innala L.,
Möller B., Ljung L. et.al.// Arthritis Res Ther. – 2011. – Vol.13(4). – P.131.
126.Danesh J. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. /Danesh J., Collins R., Appleby P., Peto R.// JAMA. –1998. –Vol.279(18). – P.1477-1482.
127.Kyzer S. Obstructive sleep apnea in the obese. /Kyzer S., Charuzi I.// World J Surg. – 1998. – Vol.22(9). – P.998-1001.
128.Biasucci L.M. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. /Biasucci L.M., Liuzzo G., Grillo R.L., Caligiuri G., Rebuzzi A.G., Buffon A., Summaria F., Ginnetti F., Fadda G., Maseri A. // Circulation. – 1999. – Vol.99(7). – P.855-860.
106
129.Marcinkowski M. Inflammatory markers 10 weeks after myocardial infarction predict future cardiovascular events. /Marcinkowski M., Czarnecka D., Jastrzebski M., Fedak D., Kawecka-Jaszcz K.// Cardiol J. – 2007. – Vol.14(1).
– P.50-58.
130.Erikssen G. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. /Erikssen G., Liestøl K., Bjørnholt J.V., Stormorken H., Thaulow E., Erikssen J.// Eur Heart J. – 2000. – Vol.21(19). – P.1614-1620.
131.Goodson N.J. Coronary artery disease and rheumatoid arthritis. /Goodson N.J.// Curr Opin Rheumatol. – 2002. – Vol.14(2). – P.115-120
132.Banerjee S. Cardiovascular outcomes in male veterans with rheumatoid arthritis. /Banerjee S., Compton A.P., Hooker R.S., Cipher D.J., Reimold A.,
Brilakis E.S., Banerjee P., Kazi S.// Am J Cardiol. – 2008. – Vol.101(8).
–P.1201-1205.
133.Gabriel S.E. Survival in rheumatoid arthritis:a population-based analysis of trends over 40 years./ Gabriel S.E., Crowson C.S., Kremers H.M. et.al// Arthritis Rheum. – 2003. – Vol.48(1). – P.54-58.
134.Heliovaara M. Rheumatoid factor, chronic arthritis and mortality. /Heliovaara M., Aho K., Knekt P., Aromaa A., Maatela J., Reunanen A.// Ann Rheum Dis.
–1995. – Vol.54(10). – P.811-814.
135.Wallberg-Jonsson S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. /Wallberg-Jonsson S., Ohman M., Dahlqvist S.// J Rheumatol. – 1997. – Vol.24(3). – P.445-451.
136.Naz S.M. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. /Naz S.M.,
107
Farragher T.M., Bunn D.K., Symmons D.P., Bruce I.N.// Arthritis Rheum.
–2008. – Vol.58(4). – P.985-989.
137.Gonzalez-Gay M.A. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. /Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., Garcia-Porrua C., Testa A., Llorca J.// J Rheumatol. – 2005. – Vol.32(7). – P.1219-1223.
138.Book C. Prediction of mortality in rheumatoid arthritis based on disease activity markers. /Book C., Saxne T., Jacobsson L.T.// J Rheumatol. – 2005.
–Vol.32(3). – P.430-434.
139.Jacobsson L.T. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. /Jacobsson L.T., Turesson C., Hanson R.L., Pillemer S, Sievers M.L., Pettitt D.J., Bennett P.H., Knowler W.C.// Arthritis Rheum. – 2001. – Vol.44(5). – P.1170-1176.
140.Mitchell D.M. Survival, prognosis, and causes of death in rheumatoid arthritis. /Mitchell D.M., Spitz P.W., Young D.Y., Bloch D.A., McShane D.J., Fries J.F. // Arthritis Rheum. – 1986. – Vol.29(6). – P.706-714.
141.Erhardt C.C. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study./ Erhardt C.C., Mumford P.A., Venables P.J., Maini R.N.// Ann Rheum Dis. – 1989. – Vol.48(1). – P.7-13.
142.Turesson C. Extra-articular rheumatoid arthritis: prevalence and mortality. /Turesson C., Jacobsson L., Bergström U.// Rheumatology (Oxford). – 1999.
–Vol.38(7). – P.668-674.
143.Turesson C. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. /Turesson C., Jarenros A., Jacobsson L.// Ann Rheum Dis. – 2004. – Vol. 63(8). – P.952-995.
108
144.Turesson C. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. /Turesson C., McClelland R.L., Christianson T.J., Matteson E.L.// Ann Rheum Dis. – 2007. – Vol.66(1). – P.70-75.
145.Pincus T. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices./Pincus T., Keysor J., Sokka T., Krishnan E., Callahan L.F.// J Rheumatol. – 2004. – Vol.31(2). – P.229-234.
146.Nadareishvili Z. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. /Nadareishvili Z., Michaud K., Hallenbeck J.M., Wolfe F.// Arthritis Rheum.
–2008. – Vol.59(8). – P.1090-1096.
147.Nurmohamed M.T. The increased cardiovascular risk in rheumatoid arthritis:
When does it start? /Nurmohamed M.T.// Arthritis Res Ther. – 2010.
–Vol.12(5). –P.140.
148.Ku I.A. Rheumatoid arthritis – a model of systemic inflammation driving atherosclerosis./ Ku I.A., Imboden J.B., Hsue P.Y., Ganz P. // Circ J. – 2009.
–Vol. 73. – P. 977-985.
149.Gamble G. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. /Gamble G., Beaumont B., Smith H., Zorn J., Sanders G., Merrilees M., MacMahon S., Sharpe N. // Atherosclerosis.
–1993. – Vol.102(2). – P.163-173.
150.Bots M.L. Intima media thickness as a surrogate marker for generalized
atherosclerosis. /Bots M.L., Grobbee D.E.// Cardiovasc Drugs Ther. – 2002.
– Vol.16(4). – P.341-351.
109
151.Stein J.H. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. /Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., Najjar S.S., Rembold C.M., Post W.S.// J Am Soc Echocardiogr. – 2008. – Vol.21(2). – P.93-111.
152.Coskun U. Relationship between carotid intima-media thickness and coronary angiographic findings:a prospective study. /Coskun U., Yildiz A., Esen O.B., Baskurt M., Cakar M.A., Kilickesmez K.O., Orhan L.A., Yildis S.// Cardiovasc Ultrasound. – 2009. – Vol. 31. – P.7-59.
153.Belcaro G. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). /Belcaro G., Nicolaides A.N., Ramaswami G., Cesarone M.R., De Sanctis M., Incandela L., Ferrari P., Geroulakos G., Barsotti A., Griffin M., Dhanjil S., Sabetai M., Bucci M., Martines G.// Atherosclerosis.
– 2001. – Vol.156(2). – P.379-387.
154.Wang T.J. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. /Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., D'Agostino R.B., O'Donnell C.J.// Arterioscler Thromb Vasc Biol. – 2002. – Vol.22(10). – P.1662-1667.
155.Xu M. Increased C-reactive protein associates with elevated carotid intimamedia thickness in Chinese adults with normal low density lipoprotein cholesterol levels. /Xu M., Bi Y., Chen Y., Xu Y., Li M., Wang T., Wang W., Ning G.// Atheroscler Thromb. – 2013. – Vol.20(6). – P.575-584.
156.Mahajan V. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. / Mahajan V., Handa R,. Kumar U., Sharma
110
S., Gulati G., Pandey R.M., Lakshmy R. // J Assoc Physicians India. – 2008.
– Vol.56. –P.587-590.
157.Targońska-Stepniak B. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. /Targońska-Stepniak B., Drelich-Zbroja A., Majdan M.// J Clin Rheumatol. – 2011. –Vol.17(5). – P.249255.
158.Galarza-Delgado D.A. Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules. /Galarza-Delgado D.A., Esquivel-Valerio J.A., Garza-Elizondo M.A., Góngora-Rivera F., Muñoz-De Hoyos J.L., Serna-Peña
G.// Reumatol Clin. – 2013. – Vol.9(3). – P.136-141.
159.del Rincón I. Effect of glucocorticoids on the arteries in rheumatoid arthritis. /del Rincón I., O'Leary D.H., Haas R.W., Escalante A.// Arthritis Rheum. – 2004.
– Vol.50(12). – P.3813-3822.
160.Kumeda Y. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. /Kumeda Y., Inaba M.,
Goto H., Nagata M., Henmi Y., Furumitsu Y., Ishimura E., Inui K., Yutani Y., Miki T., Shoji T., Nishizawa Y. // Arthritis Rheum. – 2002. – Vol.46(6).
–P.1489-1497.
161.del Rincón I. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. /del Rincón I., Freeman G.L., Haas R.W., O'Leary D.H., Escalante A.// Arthritis Rheum. – 2005.
–Vol.52(11). – P.3413-3423.
162.del Porto F. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. /del Porto F., Laganà B., Lai S., Nofroni I., Tinti F., Vitale M., Podestà E., Mitterhofer A.P., D'Amelio R. // Rheumatology (Oxford). – 2007.
–Vol.46(7). – P.1111-1115.